|
TTC26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63624669369256E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.62009999649504E-08 |
| Normal-vs-Stage2 |
2.513500E-02 |
| Normal-vs-Stage3 |
2.983000E-03 |
| Normal-vs-Stage4 |
6.242300E-02 |
| Stage1-vs-Stage2 |
7.562000E-01 |
| Stage1-vs-Stage3 |
6.182600E-01 |
| Stage1-vs-Stage4 |
2.551600E-01 |
| Stage2-vs-Stage3 |
9.759600E-01 |
| Stage2-vs-Stage4 |
6.396600E-01 |
| Stage3-vs-Stage4 |
6.011600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99873451123267E-12 |
| Normal-vs-AfricanAmerican |
8.26830000000278E-05 |
| Normal-vs-Asian |
2.404400E-01 |
| Caucasian-vs-AfricanAmerican |
1.106050E-02 |
| Caucasian-vs-Asian |
4.955600E-01 |
| AfricanAmerican-vs-Asian |
9.453800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.82958117942189E-12 |
| Normal-vs-Female |
7.42380000029463E-07 |
| Male-vs-Female |
1.500050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.362010E-03 |
| Normal-vs-Extreme_Weight |
1.153390E-04 |
| Normal-vs-Obese |
2.68190000207724E-08 |
| Normal-vs-Extreme_Obese |
2.253800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.304000E-01 |
| Normal_Weight-vs-Obese |
2.375800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.877200E-01 |
| Extreme_Weight-vs-Obese |
6.722600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.791800E-01 |
| Obese-vs-Extreme_Obese |
6.309400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.497950E-03 |
| Normal-vs-Age(41-60Yrs) |
2.82129875017745E-11 |
| Normal-vs-Age(61-80Yrs) |
1.15129999977981E-07 |
| Normal-vs-Age(81-100Yrs) |
8.938100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.604190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.834400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.862600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.367800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.444400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.765400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.44249065417534E-15 |
| Normal-VS-Type2 PRCC |
1.395230E-03 |
| Normal-VS-KIRP CIMP |
4.548600E-01 |
| Normal-VS-Unclassified PRCC |
2.603800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.662100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.831400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.313000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.315380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.020000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.038900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.480000E-03 |
| Normal-vs-N1 |
1.115180E-03 |
| Normal-vs-N2 |
3.3751999994891E-07 |
| N0-vs-N1 |
1.442960E-01 |
| N0-vs-N2 |
9.084000E-01 |
| N1-vs-N2 |
1.023630E-01 |
|
|
